Tuberculosis and Mycobacterial Diseases

Tuberculosis (TB), caused by Mycobacterium tuberculosis, remains one of the deadliest infectious diseases globally. It primarily affects the lungs but can also involve other organs such as the spine, kidneys, and brain. TB spreads through airborne particles and thrives in overcrowded or resource-limited settings. Despite the availability of effective antibiotics, TB control is hampered by drug resistance, with multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains posing significant treatment challenges. In addition to TB, nontuberculous mycobacteria (NTM) are emerging as important pathogens, especially in individuals with underlying lung conditions or weakened immunity. Diagnosis of mycobacterial infections can be complex and often delayed due to slow-growing organisms and non-specific symptoms. Enhancing diagnostic tools, promoting treatment adherence, and strengthening public health strategies are essential for managing TB and related diseases. Vaccination, early detection, and improved access to care remain critical in reducing transmission and mortality.

    Related Conference of Tuberculosis and Mycobacterial Diseases

    August 28-29, 2025

    8th Pathology and Infectious Disease Conference

    London, UK
    September 22-23, 2025

    11th International Conference on Infectious and Rare Diseases

    Vancouver, Canada
    December 11-12, 2025

    8th Annual Congress on Bacterial, Viral and Infectious Diseases

    Prague, Czech Republic
    December 15-16, 2025

    7th Global Experts Meeting on Infectious Diseases

    Barcelona, Spain
    December 17-18, 2025

    17th Global Conference on Nephrology and Infectious Diseases

    Amsterdam, Netherlands
    May 18-19, 2026

    15th World Congress on Rare Diseases and Orphan Drugs

    Prague, Czech Republic

    Tuberculosis and Mycobacterial Diseases Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in